These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 30674626)

  • 1. Effective Suppression of HIV-1 Replication by Cytotoxic T Lymphocytes Specific for Pol Epitopes in Conserved Mosaic Vaccine Immunogens.
    Zou C; Murakoshi H; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Hanke T; Takiguchi M
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30674626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8
    Murakoshi H; Zou C; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Hanke T; Takiguchi M
    Retrovirology; 2018 Jul; 15(1):46. PubMed ID: 29970102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad Recognition of Circulating HIV-1 by HIV-1-Specific Cytotoxic T-Lymphocytes with Strong Ability to Suppress HIV-1 Replication.
    Murakoshi H; Kuse N; Akahoshi T; Zhang Y; Chikata T; Borghan MA; Gatanaga H; Oka S; Sakai K; Takiguchi M
    J Virol; 2019 Jan; 93(1):. PubMed ID: 30333175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.
    Murakoshi H; Akahoshi T; Koyanagi M; Chikata T; Naruto T; Maruyama R; Tamura Y; Ishizuka N; Gatanaga H; Oka S; Takiguchi M
    J Virol; 2015 May; 89(10):5330-9. PubMed ID: 25741000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of HIV-1 replication in vitro by vaccine-induced human CD8(+) T cells through conserved subdominant Pol epitopes.
    Ahmed T; Borthwick NJ; Gilmour J; Hayes P; Dorrell L; Hanke T
    Vaccine; 2016 Feb; 34(9):1215-24. PubMed ID: 26784683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of highly conserved and broadly cross-reactive HIV type 1 cytotoxic T lymphocyte epitopes as candidate immunogens for inclusion in Mycobacterium bovis BCG-vectored HIV vaccines.
    Ferrari G; Kostyu DD; Cox J; Dawson DV; Flores J; Weinhold KJ; Osmanov S
    AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1433-43. PubMed ID: 11018863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients.
    Durali D; Morvan J; Letourneur F; Schmitt D; Guegan N; Dalod M; Saragosti S; Sicard D; Levy JP; Gomard E
    J Virol; 1998 May; 72(5):3547-53. PubMed ID: 9557634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of HLA-A*3303-restricted, HIV type 1 Pol- and Gag-derived cytotoxic T cell epitopes.
    Hossain MS; Tomiyama H; Inagawa T; Ida S; Oka S; Takiguchi M
    AIDS Res Hum Retroviruses; 2003 Jun; 19(6):503-10. PubMed ID: 12882660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping HIV-1 vaccine induced T-cell responses: bias towards less-conserved regions and potential impact on vaccine efficacy in the Step study.
    Li F; Finnefrock AC; Dubey SA; Korber BT; Szinger J; Cole S; McElrath MJ; Shiver JW; Casimiro DR; Corey L; Self SG
    PLoS One; 2011; 6(6):e20479. PubMed ID: 21695251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
    J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1.
    Borthwick N; Ahmed T; Ondondo B; Hayes P; Rose A; Ebrahimsa U; Hayton EJ; Black A; Bridgeman A; Rosario M; Hill AV; Berrie E; Moyle S; Frahm N; Cox J; Colloca S; Nicosia A; Gilmour J; McMichael AJ; Dorrell L; Hanke T
    Mol Ther; 2014 Feb; 22(2):464-475. PubMed ID: 24166483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of HIV-1 Replication by CD8
    Nguyen HT; Kuse N; Zhang Y; Murakoshi H; Maeda Y; Tamura Y; Maruyama R; Tran GV; Nguyen TV; Nguyen KV; Oka S; Chikata T; Takiguchi M
    J Virol; 2022 Oct; 96(19):e0081122. PubMed ID: 36154612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1.
    Wilson CC; McKinney D; Anders M; MaWhinney S; Forster J; Crimi C; Southwood S; Sette A; Chesnut R; Newman MJ; Livingston BD
    J Immunol; 2003 Nov; 171(10):5611-23. PubMed ID: 14607970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gag and env conserved element CE DNA vaccines elicit broad cytotoxic T cell responses targeting subdominant epitopes of HIV and SIV Able to recognize virus-infected cells in macaques.
    Hu X; Lu Z; Valentin A; Rosati M; Broderick KE; Sardesai NY; Marx PA; Mullins JI; Pavlakis GN; Felber BK
    Hum Vaccin Immunother; 2018; 14(9):2163-2177. PubMed ID: 29939820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of a human immunodeficiency virus (HIV) polytope vaccine containing multiple HLA A2 HIV CD8(+) cytotoxic T-cell epitopes.
    Woodberry T; Gardner J; Mateo L; Eisen D; Medveczky J; Ramshaw IA; Thomson SA; Ffrench RA; Elliott SL; Firat H; Lemonnier FA; Suhrbier A
    J Virol; 1999 Jul; 73(7):5320-5. PubMed ID: 10364278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of cross-clade CTL epitopes in HIV-1 clade A/E-infected individuals by using the clade B overlapping peptides.
    Watanabe K; Murakoshi H; Tamura Y; Koyanagi M; Chikata T; Gatanaga H; Oka S; Takiguchi M
    Microbes Infect; 2013 Nov; 15(13):874-86. PubMed ID: 23968885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys.
    Santra S; Liao HX; Zhang R; Muldoon M; Watson S; Fischer W; Theiler J; Szinger J; Balachandran H; Buzby A; Quinn D; Parks RJ; Tsao CY; Carville A; Mansfield KG; Pavlakis GN; Felber BK; Haynes BF; Korber BT; Letvin NL
    Nat Med; 2010 Mar; 16(3):324-8. PubMed ID: 20173754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection and accumulation of an HIV-1 escape mutant by three types of HIV-1-specific cytotoxic T lymphocytes recognizing wild-type and/or escape mutant epitopes.
    Akahoshi T; Chikata T; Tamura Y; Gatanaga H; Oka S; Takiguchi M
    J Virol; 2012 Feb; 86(4):1971-81. PubMed ID: 22156528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of escape mutant by HLA-C-restricted HIV-1 Pol-specific cytotoxic T lymphocytes carrying strong ability to suppress HIV-1 replication.
    Honda K; Zheng N; Murakoshi H; Hashimoto M; Sakai K; Borghan MA; Chikata T; Koyanagi M; Tamura Y; Gatanaga H; Oka S; Takiguchi M
    Eur J Immunol; 2011 Jan; 41(1):97-106. PubMed ID: 21182081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses.
    Murakoshi H; Koyanagi M; Chikata T; Rahman MA; Kuse N; Sakai K; Gatanaga H; Oka S; Takiguchi M
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27903797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.